Literature DB >> 18663491

kNNsim: k-nearest neighbors similarity with genetic algorithm features optimization enhances the prediction of activity classes for small molecules.

Dariusz Plewczynski1.   

Abstract

Protein targets specificity classification is an important step in computational drug development and design efforts. The enhanced classification models of small chemical molecules enable the rapid scanning of large compounds databases. Here, we present the k-nearest neighbors with genetic algorithm feature optimization approach for selection of small molecule protein inhibitors. The method is trained on selected, diverse activity classes of the MDL drug data report (MDDR) with ligands described using simple atom pairs two dimensional chemical descriptors. The accuracy of inhibitors identification is presented in confusion tables with calculated recall and precision values. The precision for selected types of targets exceeded 70%, and the recall reaches 40%. As a consequence, the method can be easily applied to large commercial compounds collections in a drug development campaign in order to significantly reduce the number of ligands for further costly experimental validation.

Mesh:

Substances:

Year:  2008        PMID: 18663491     DOI: 10.1007/s00894-008-0349-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  21 in total

1.  The centroid approximation for mixtures: calculating similarity and deriving structure--activity relationships.

Authors:  R P Sheridan
Journal:  J Chem Inf Comput Sci       Date:  2000 Nov-Dec

2.  Novel variable selection quantitative structure--property relationship approach based on the k-nearest-neighbor principle

Authors: 
Journal:  J Chem Inf Comput Sci       Date:  2000-01

3.  A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication.

Authors:  Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2005 Sep-Oct       Impact factor: 4.956

4.  In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect prediction.

Authors:  Zhi Liang Ji; Yi Wang; Lin Yu; Lian Yi Han; Chan Juan Zheng; Yu Zong Chen
Journal:  Toxicol Lett       Date:  2006-03-23       Impact factor: 4.372

5.  Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors.

Authors:  James H Nettles; Jeremy L Jenkins; Andreas Bender; Zhan Deng; John W Davies; Meir Glick
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

6.  Assessing different classification methods for virtual screening.

Authors:  Dariusz Plewczynski; Stéphane A H Spieser; Uwe Koch
Journal:  J Chem Inf Model       Date:  2006 May-Jun       Impact factor: 4.956

7.  Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases.

Authors:  Meir Glick; John W Davies; Jeremy L Jenkins
Journal:  J Chem Inf Model       Date:  2006 May-Jun       Impact factor: 4.956

8.  Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.

Authors:  Andreas Bender; Josef Scheiber; Meir Glick; John W Davies; Kamal Azzaoui; Jacques Hamon; Laszlo Urban; Steven Whitebread; Jeremy L Jenkins
Journal:  ChemMedChem       Date:  2007-06       Impact factor: 3.466

9.  Target specific compound identification using a support vector machine.

Authors:  Dariusz Plewczynski; Marcin von Grotthuss; Stephane A H Spieser; Leszek Rychlewski; Lucjan S Wyrwicz; Krzysztof Ginalski; Uwe Koch
Journal:  Comb Chem High Throughput Screen       Date:  2007-03       Impact factor: 1.339

10.  Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm.

Authors:  M L Raymer; P C Sanschagrin; W F Punch; S Venkataraman; E D Goodman; L A Kuhn
Journal:  J Mol Biol       Date:  1997-01-31       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.